3M said it completed the separation of its Health Care business on April 1, 2024 through a pro rata distribution of 80.1% of the outstanding shares of Solventum Corporation to 3M shareholders. The historical net income of Solventum and applicable assets and liabilities included in the separation are reported as discontinued operations.

1. 01

   3M said it completed the separation of its Health Care business on April 1, 2024 through a pro rata distribution of 80.1% of the outstanding shares of Solventum Corporation to 3M shareholders. The historical net income of Solventum and applicable assets and liabilities included in the separation are reported as discontinued operations.

2. 02

   The company said the effective tax rates for 2024, 2023 and 2022 were 16.7%, 25.4% and 4.5%, respectively, and on an adjusted basis the effective tax rates were 19.6%, 19.2% and 16.6%, respectively.

3. 03

   3M said operating cash flow in 2024 decreased by $4.9 billion year-on-year, citing as primary factors payments of approximately $4.6 billion associated with PFAS-related other environmental liabilities and the CAE settlement.

4. 04

   3M said that as of December 31, 2024, cash, cash equivalents and marketable securities were $7.7 billion, compared to $5.8 billion as of December 31, 2023. The company had no commercial paper outstanding at the end of 2024 and $1.8 billion outstanding at the end of 2023.

Key figures

Fiscal year ended December 31, 2024

Revenue

$24.6B

Operating income

$4.8B

Net income

$4.2B

EPS

$7.55

Operating cash flow

$1.8B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.